Advertisement

Modulatory Role of NK1 Receptors in the Basal Ganglia. Studies in NK1-/- Mice

  • Laura Turpín
  • Jorge Boronat
  • Carlos Barcia
  • María Gómez
  • Francisco Ros
  • Virginia García
  • Stephen P Hunt
  • Carmen de Felipe
  • María-Trinidad Herrero
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 56)

Keywords

Basal Ganglion Dorsal Raphe Nucleus MPTP Treatment Tachykinin Receptor Entopeduncular Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6. References

  1. 1.
    Donalson, L., Haskell, C.A., and Hanley, M.R, 2001, Messenger RNA localisation and further characterization of the putative tachykinin receptor NK4 (NK3B). Receptors channels 7:259–227.Google Scholar
  2. 2.
    Regoli, D., Drapeau, G., Dion, S., and D’Orleans-Juste, P., 1989, Receptors for substance P and related neurokinins. Pharmacology 38:1–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Nakanishi, S., 1991, Mammalian tachykinin receptors. Annu. Rev. Neuroscience 14:123–136.CrossRefGoogle Scholar
  4. 4.
    Li, J.L., Wang, D., Kaneko, T., Shigemoto, R., Nomura, S., and Mizuno, N., 2000, Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat. J. Comp. Neurol. 418:156–163.PubMedCrossRefGoogle Scholar
  5. 5.
    Ljungdahl, A., Hökfelt, T., and Nilsson, G., 1978, Distribution of substance P-like immunoreactivity in the central nervous system of the rat-I. Cell bodies and nerve terminals. Neuroscience 3:861–943.PubMedCrossRefGoogle Scholar
  6. 6.
    Maggio, J.E., Sandberg, B.E.B., Bradley, C.V., Iversen, L., Santikan, S., Williams, B.H., Hunter, J.C., and Hanley, M.R., 1983, Substance K: a novel tachykinin in mammalian spinal cord. In: Substance P. Ed by Skrabanek P. and Powell D. pp. 20–21. Boole, Dublin.Google Scholar
  7. 7.
    Reid, M.S., Herrera-Marschitz, M., Kehr, J., and Ungerstedt, U., 1990, Striatal dopamine and glutamate release: effects of intranigral injections of substance P. Acta. Physiol. Scand. 140:527–537.PubMedCrossRefGoogle Scholar
  8. 8.
    Patacchini, R., and Maggi, C.A., 1995, Tachykinin receptors and receptor subtypes. Arch. Int. Pharmacodyn Ther. 329:161–184.PubMedGoogle Scholar
  9. 9.
    Saria, A., 1999, The tachykinin NK1 receptor in the brain: pharmacology and putative functions. Eur. J. Pharmacol. 375:51–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Hökfelt, T., Pernow, B., and Wahren, J., 2001, Substance P: a pioneer amongst neuropeptides. J. Intern. Med. 249:27–40.PubMedCrossRefGoogle Scholar
  11. 11.
    Mantyh, P.W., 2002, Neurobiology of substance P and the NK1 receptor. J. Clin. Psychiatry 63 Suppl 11:6–10.Google Scholar
  12. 12.
    Whitty, C.J., Walker, P.D., Goebel, D.J., Poosch, M.S., and Bannon, M.J., 1995, Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience 64:419–425.PubMedCrossRefGoogle Scholar
  13. 13.
    Maggi, C.A., Patacchini, R., Rovero, P., and Giachetti, A., 1993, Tachykinin receptors and tachyikinin receptors antagonist. J. Auton. Pharmacol. 13:23–93.PubMedCrossRefGoogle Scholar
  14. 14.
    Liu, H.L., Cao, R., Jin, L., and Chen, L.W., 2002, Immunocytochemical localization of substance P receptor in hypothalamic oxytocin-containing neurons of C57 mice. Brain Res. 948:175–179.PubMedCrossRefGoogle Scholar
  15. 15.
    Beaujouan, J.C., Saffroy, M., Torrens, Y., and Glowinski, J., 2000, Differents subtypes of tachykinin NK1 receptor binding sites are present in the rat brain. J. Neurochem. 75:1015–1026.PubMedCrossRefGoogle Scholar
  16. 16.
    Chen, L.W., Wei, L.C., Liu, H.L., and Rao, Z.R., 2000, Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat. Brain Res. 873:155–159.PubMedCrossRefGoogle Scholar
  17. 17.
    Commons, K.G., and Valentino, R.S., 2002, Cellular basis for the effects of substance P in the periaqueductal grey and dorsal raphe nucleus. J. Comp. Neurol. 39:1–8.Google Scholar
  18. 18.
    Elde, R., Schalling, M., Ceccatelli, S., Nakanishi, S., and Hökfelt, T., 1990, Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors. Neurosci. Lett. 120:134–138.PubMedCrossRefGoogle Scholar
  19. 19.
    Kowall, N.W., Quigley, B.J. Jr, Krause, J.E., Lu, F., Kosofsky, B.E., and Ferrante. R.J., 1993, Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regul. Pept. 46(1–2):174–185.PubMedCrossRefGoogle Scholar
  20. 20.
    Gerfen, C.R., 1991, Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556:165–170.PubMedCrossRefGoogle Scholar
  21. 21.
    Aubry, J.M., Lundstrom, K., Kawashima, E., Ayala, G., Schulz, P., Bartanusz, V., and Kiss, J.Z, 1994, NK1 receptor expression by cholinergic interneurons in human striatum. Neuroreport. 15; 5(13):1597–1600.PubMedCrossRefGoogle Scholar
  22. 22.
    Kaneko, T., Shigemoto, R., Nakanishi, S., and Mizuno, N., 1993, Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631:297–303.PubMedCrossRefGoogle Scholar
  23. 23.
    Shigemoto, R., Nakaya, Y., Nomura, S., Ogawa-Meguro, R., Ohishi, H., Kaneko, T., Nakanishi, S., and Mizuno, N., 1993, Immunocytochemical localization of rat substance P receptor in the striatum. Neurosci. Lett. 153:157–160.PubMedCrossRefGoogle Scholar
  24. 24.
    Jakab, R.L., Hazrati, L.N., and Golin, P., 1996, Distribution and neurochemical behaviour of substance P receptor (SP immunoreactive striatal neurons of macaque monkey: accumulation of substance P fibers and SPR neurons and dendrites in striocapsules encircled striosomes. J. Comp. Neurol. 369:137–149.PubMedCrossRefGoogle Scholar
  25. 25.
    Parent, A., Cichtti, F., and Beach, T.G., 1995, Striatal neurons displaying substance P (NK1) receptor immunoreactivity in human and no-human primate. Neuroreport 6:721–724.PubMedCrossRefGoogle Scholar
  26. 26.
    Mounir, S., and Parent, A., 2002, The expression of neurokinin-1 receptor at striatal and pallidal levels in normal human brain. Neurosci. Res. 44:71–81.PubMedCrossRefGoogle Scholar
  27. 27.
    Bannon, M.J., and Whitty, C.J., 1995, Neurokinin receptor gene expression in substantia nigra: localization, regulation, and potential physiological significance. Can J. Physiol. Pharmacol. 73:866–870.PubMedGoogle Scholar
  28. 28.
    Mileusnic, D., Lee, J.M., Magnuson, D.J., Hejna, M.J., Krause, J.E., Lorens, J.B., and Lorens, S.A., 1999, Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 89:1269–1290.PubMedCrossRefGoogle Scholar
  29. 29.
    Levesque, M., Bedard, A., and Parent, A., 2003, Novel aspect of the chemical anatomy of the striatum and its efferents projections. J. Chem. Neuroanatomy 26:271–281.CrossRefGoogle Scholar
  30. 30.
    Levy, R., Hazrati, L.N., Herrero, M.T., Vila, M., Hassani, O.K., Moroux, M., Ruberg, M., Asensi, H., Agid, Y., Feger, J., Obeso, J.A., Parent, A., and Hirsch, E.C., 1997, Re-evaluation of the functional anatomy of the basal ganglia in normal and in Parkinson states. Neuroscience 76:335–343.PubMedCrossRefGoogle Scholar
  31. 31.
    Herrero, M.T., Augood, S.J., Hirsch, E.C., Javoy-Agid, F., Luquin, M.R., Agid, Y., Obeso, J.A., and Emson, P.C., 1995, Effects of L-DOPA on pre-proenkephalin and pre-protachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 68:1189–1198.PubMedCrossRefGoogle Scholar
  32. 32.
    Herrero, M.T., Levy, R., Luquin, M.R., Villares, J., Guillen, J., Faucheux, B., Javoy-Agid, F., Obeso, J.A., and Hirsch, E.C., 1996, Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology 47:219–224.PubMedCrossRefGoogle Scholar
  33. 33.
    Vila, M., Levy, R., Herrero, M.T., Ruberg, M., Faucheux, B., Obeso, J.A., Agid, Y., and Hirsch, E.C., 1997, Consequences of nigroestriatal denervation on the functioning of the basal ganglia in human and non human primates: an in situ hybridization study of cytochrome oxydase subunit I mRNA. J. Neurosci. 17:765–773.PubMedGoogle Scholar
  34. 34.
    De Felipe, C., Herrero, J.F., O’Brien, J., Palmer, J., Doyle, C.A., Smith, A., Laird, J.M.A., Belmonte, Cervero, F., and Hunt, S., 1998, Altered nociceptor in analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394–397.PubMedCrossRefGoogle Scholar
  35. 35.
    Rigual, R., Rico, A., Prieto-Lloret, J., De Felipe, C., and Donnelly, D., 2002, Chemoreceptor activity is normal in mice lacking the NK1 receptor. Eur. J. Neurosci. 16:2078–2084.PubMedCrossRefGoogle Scholar
  36. 36.
    Herrero, M.T., Hirsch, E.C., Kastner, A., Ruberg, M., Luquin, M.R., Laguna, L., Javoy-Agid, F., Obeso, J.A., and Agid, Y., 1993, Does Neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56:499–511.PubMedCrossRefGoogle Scholar
  37. 37.
    Fontaine, B., Sassoon, D., Buckingham, M., and Changeux, J.P., 1988, Detection of nicotinic acetylcholine receptor a-subunit mRNA by in situ hybridization at neuromuscular junction of 15 day-old chick striatal muscles, EMBO J. 7:603–609.PubMedGoogle Scholar
  38. 38.
    Paxinos, G., and Franklin, B.J. The mouse brain in stereotaxic coordinates, 2001. Academic Press.Google Scholar
  39. 39.
    Sterio, D.C., 1984, The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134:127–136.PubMedGoogle Scholar
  40. 40.
    Bannon, M.J., and Whitty, C., J., 1995, Neurokinin receptor gene expression in the substantia nigra: location, regulation and potential physiological significant. Can J. Physiol. Pharmacol. 73:866–870.PubMedGoogle Scholar
  41. 41.
    Whitty, C.J., Paul, M.A., and Bannon, M.J., 1997, Neurokinin receptor: mRNA localization in human midbrain dopamine neurons. J. Comp. Neurol. 382:394–400.PubMedCrossRefGoogle Scholar
  42. 42.
    Saffroy, M., Beaujouan, J.C., Torrens, Y., Besseyre, J., Bergstrom, L., and Glowinski, J., 1988, Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides 9:227–241.PubMedCrossRefGoogle Scholar
  43. 43.
    Mauborgne, A., Javoy-Agid, F., Legrand, J.C., Agid, Y., and Cesselin, F., 1983, Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res. 268:167–170.PubMedCrossRefGoogle Scholar
  44. 44.
    Rioux, L., and Joyce, J.N., 1993, Substance P receptors are differentially affected in Parkinson’s and Alzheimer disease. J. Neural. Transm. Park Dis. Dement. Sect. 6:199–210.PubMedCrossRefGoogle Scholar
  45. 45.
    Drago, J., Mc Coll, C.D., Horne, M.K., Finkelstein, D.I., and Ross, S.A., 2003, Neuronal nicotinic receptors: insights gained from gene knockout and knock in mutant mice, Cell Mol. Life Sci. 60:1267–1280.PubMedCrossRefGoogle Scholar
  46. 46.
    Lindefors, N., 1993, Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog. Neuropsychopharmacol Biol. Psychiatry 17:887–903.PubMedCrossRefGoogle Scholar
  47. 47.
    Guridi, J., Herrero, M.T., Luquin, M.R., Guillen, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E., and Obeso, J.A., 1996, Subthalamotomy in parkinsonian monkeys. Behavioural and Biochemical Analysis. Brain 119:1717–1727.PubMedCrossRefGoogle Scholar
  48. 48.
    Soghomonian, J.J., and Chesselet, M.F., 1992, Effects of nigrostriatal lesion on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11:124–133.PubMedCrossRefGoogle Scholar
  49. 49.
    Ding, Y.Q., Zheng, H.X., Wang, D.S., Xu, J.Q., Gong, L.W., Lu, Y., Qin, B.Z., Shi, J., Li, H.L., Li, J.S., Shigemoto, R., Kaneko, T., and Mizuno, N., 1999, The distribution of substance P receptor (NK1)-like immunoreactive neurons in the new-born and adult human spinal cord. Neurosci. Lett. 266:133–136.PubMedCrossRefGoogle Scholar
  50. 50.
    Maurer, C., Mergner, T., Xie, J., Faist, M., Pollak, P., and Lucking, C.H., 2003, Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson’s disease. Brain 126:1146–1163.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Laura Turpín
    • 1
  • Jorge Boronat
    • 1
  • Carlos Barcia
    • 1
  • María Gómez
    • 1
  • Francisco Ros
    • 1
  • Virginia García
    • 1
  • Stephen P Hunt
    • 2
  • Carmen de Felipe
    • 3
  • María-Trinidad Herrero
    • 1
  1. 1.Experimental Neurology & Neurosurgery. School of MedicineUniversity of MurciaMurciaSpain
  2. 2.Department of Anatomy & Developmental BiologyUniversity College LondonLondonUK
  3. 3.Instituto de NeurocienciasUniversitas Miguel HernándezAlicanteSpain

Personalised recommendations